606 related articles for article (PubMed ID: 10464010)
1. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
Camps P; El Achab R; Görbig DM; Morral J; Muñoz-Torrero D; Badia A; Eladi Baños J; Vivas NM; Barril X; Orozco M; Luque FJ
J Med Chem; 1999 Aug; 42(17):3227-42. PubMed ID: 10464010
[TBL] [Abstract][Full Text] [Related]
2. New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.
Camps P; El Achab R ; Morral J; Muñoz-Torrero D; Badia A; Baños JE; Vivas NM; Barril X; Orozco M; Luque FJ
J Med Chem; 2000 Nov; 43(24):4657-66. PubMed ID: 11101357
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
Badia A; Baños JE; Camps P; Contreras J; Görbig DM; Muñoz-Torrero D; Simón M; Vivas NM
Bioorg Med Chem; 1998 Apr; 6(4):427-40. PubMed ID: 9597187
[TBL] [Abstract][Full Text] [Related]
4. Discovery of huperzine A-tacrine hybrids as potent inhibitors of human cholinesterases targeting their midgorge recognition sites.
Gemma S; Gabellieri E; Huleatt P; Fattorusso C; Borriello M; Catalanotti B; Butini S; De Angelis M; Novellino E; Nacci V; Belinskaya T; Saxena A; Campiani G
J Med Chem; 2006 Jun; 49(11):3421-5. PubMed ID: 16722663
[TBL] [Abstract][Full Text] [Related]
5. Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
Camps P; Formosa X; Galdeano C; Gómez T; Muñoz-Torrero D; Scarpellini M; Viayna E; Badia A; Clos MV; Camins A; Pallàs M; Bartolini M; Mancini F; Andrisano V; Estelrich J; Lizondo M; Bidon-Chanal A; Luque FJ
J Med Chem; 2008 Jun; 51(12):3588-98. PubMed ID: 18517184
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and pharmacological profile of novel fused pyrazolo[4,3-d]pyridine and pyrazolo[3,4-b][1,8]naphthyridine isosteres: a new class of potent and selective acetylcholinesterase inhibitors.
Barreiro EJ; Camara CA; Verli H; Brazil-Más L; Castro NG; Cintra WM; Aracava Y; Rodrigues CR; Fraga CA
J Med Chem; 2003 Mar; 46(7):1144-52. PubMed ID: 12646025
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
Shao D; Zou C; Luo C; Tang X; Li Y
Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine.
Tumiatti V; Rosini M; Bartolini M; Cavalli A; Marucci G; Andrisano V; Angeli P; Banzi R; Minarini A; Recanatini M; Melchiorre C
J Med Chem; 2003 Mar; 46(6):954-66. PubMed ID: 12620072
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease.
Maalej E; Chabchoub F; Oset-Gasque MJ; Esquivias-Pérez M; González MP; Monjas L; Pérez C; de los Ríos C; Rodríguez-Franco MI; Iriepa I; Moraleda I; Chioua M; Romero A; Marco-Contelles J; Samadi A
Eur J Med Chem; 2012 Aug; 54():750-63. PubMed ID: 22795665
[TBL] [Abstract][Full Text] [Related]
10. Rational design and synthesis of highly potent anti-acetylcholinesterase activity huperzine A derivatives.
Yan J; Sun L; Wu G; Yi P; Yang F; Zhou L; Zhang X; Li Z; Yang X; Luo H; Qiu M
Bioorg Med Chem; 2009 Oct; 17(19):6937-41. PubMed ID: 19726199
[TBL] [Abstract][Full Text] [Related]
11. Predicting relative binding free energies of tacrine-huperzine A hybrids as inhibitors of acetylcholinesterase.
Barril X; Orozco M; Luque FJ
J Med Chem; 1999 Dec; 42(25):5110-9. PubMed ID: 10602696
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and acetylcholinesterase/butyrylcholinesterase inhibition activity of 4-amino-2, 3-diaryl-5, 6, 7, 8-tetrahydrofuro(and thieno)[2, 3-b]-quinolines, and 4-amino-5, 6, 7, 8, 9-pentahydro-2, 3-diphenylcyclohepta[e]furo(and thieno)-[2, 3-b]pyridines.
Marco JL; De Los Ríos C; Carreiras MC; Baños JE; Badia A; Vivas NM
Arch Pharm (Weinheim); 2002 Jul; 335(7):347-53. PubMed ID: 12207285
[TBL] [Abstract][Full Text] [Related]
13. Tacrine-huperzine A hybrids (huprines): a new class of highly potent and selective acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.
Camps P; Muñoz-Torrero D
Mini Rev Med Chem; 2001 Jul; 1(2):163-74. PubMed ID: 12369981
[TBL] [Abstract][Full Text] [Related]
14. New tacrine-dihydropyridine hybrids that inhibit acetylcholinesterase, calcium entry, and exhibit neuroprotection properties.
León R; de los Ríos C; Marco-Contelles J; Huertas O; Barril X; Luque FJ; López MG; García AG; Villarroya M
Bioorg Med Chem; 2008 Aug; 16(16):7759-69. PubMed ID: 18640842
[TBL] [Abstract][Full Text] [Related]
15. New multipotent tetracyclic tacrines with neuroprotective activity.
Marco-Contelles J; León R; de los Ríos C; García AG; López MG; Villarroya M
Bioorg Med Chem; 2006 Dec; 14(24):8176-85. PubMed ID: 17005406
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of tacrine-thiadiazolidinone hybrids as dual acetylcholinesterase inhibitors.
Dorronsoro I; Alonso D; Castro A; del Monte M; García-Palomero E; Martínez A
Arch Pharm (Weinheim); 2005 Jan; 338(1):18-23. PubMed ID: 15674800
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.
Korabecny J; Musilek K; Holas O; Binder J; Zemek F; Marek J; Pohanka M; Opletalova V; Dohnal V; Kuca K
Bioorg Med Chem Lett; 2010 Oct; 20(20):6093-5. PubMed ID: 20817518
[TBL] [Abstract][Full Text] [Related]
18. Identification of amino acid residues involved in the binding of Huperzine A to cholinesterases.
Saxena A; Qian N; Kovach IM; Kozikowski AP; Pang YP; Vellom DC; Radić Z; Quinn D; Taylor P; Doctor BP
Protein Sci; 1994 Oct; 3(10):1770-8. PubMed ID: 7849595
[TBL] [Abstract][Full Text] [Related]
19. Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties.
Fernández-Bachiller MI; Pérez C; Campillo NE; Páez JA; González-Muñoz GC; Usán P; García-Palomero E; López MG; Villarroya M; García AG; Martínez A; Rodríguez-Franco MI
ChemMedChem; 2009 May; 4(5):828-41. PubMed ID: 19308922
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
Keri RS; Quintanova C; Marques SM; Esteves AR; Cardoso SM; Santos MA
Bioorg Med Chem; 2013 Aug; 21(15):4559-69. PubMed ID: 23768661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
